What is Novavax Inc.?
Novavax Inc. is a late-stage biotechnology company focused on the discovery, development and commercialisation of innovative vaccines to prevent infectious diseases. Novavax was founded in 1987 and is headquartered in Gaithersburg, Maryland. It produces vaccine candidates to respond to both known and emerging diseases through the use of proprietary technology. It also develops and produces immune stimulants using saponin-based adjuvants through a wholly owned Swedish subsidiary, Novavax AB.
Novavax has risen in notoriety recently after being selected to be part of the US government vaccine strategy, Operation Warp Speed. The government supported their efforts to develop an effective coronavirus vaccine with an investment of $1.6bn (£1.2bn, €1.4bn) in an effort to speed up development.
The company has also secured more than $500m in preorder contracts with other governments to be exercised if and when a successful vaccine is developed. Novavax also has vaccines for seasonal influenza, Ebola, MERS, SARS and RSV at varying stages in its pipeline, although it is currently focusing the majority of resources on a coronavirus vaccine.
Past performance of Novavax stock
Novavax stock trading began on December 5, 1995. The company did not issue an IPO but was formed through a triangular reverse merger of Lipovax, Novavax and MPS (a subsidiary created specifically to complete the merger). The starting price of the newly formed company was set at $67.50. There has been one split since 1995 which was a 1 for 20 reverse stock split on May 10, 2019, a requirement for the company to stay within the financial parameters required by the NASDAQ exchange. This required split should be a hint that it has not always been a smooth ride for the Novavax stock price. The all-time high of $300.60 was reached on October 9, 2001 as the price soared on the optimism of a promising RSV vaccine, which failed to materialise. As the information that the vaccine would not be successful emerged, the price crashed and has remained volatile ever since. Enter 2020, and the global need for a vaccine to combat the coronavirus pandemic, and the Novavax stock price is flying high once again.
To track the price today you can view the price chart.
How to invest in Novavax stock
Novavax stock trading occurs on the NASDAQ exchange under the ticker symbol NVAX. Traditionally, those looking to invest in Novavax stock would purchase shares or derivatives based on NVAX through a broker.
Traders using the Dzengi.com tokenised platform are able to profit from movements in the Novavax stock price without having to invest in Novavax stock directly. Tokens are crypto derivatives whose value is linked to the value of a particular asset, in this case the share price. The token is registered using distributed ledger technology (DLT) the same way cryptocurrency is recorded. This technology allows for trading with crypto without requiring conversion from fiat. Utilising DLT makes tokenised assets trading efficient, inexpensive, and secure.
Tokenised Novavax stock trading guide
Trading tokenised Novavax shares is no more difficult than regular stock. To begin trading tokenised assets, you will follow need to follow some simple steps:
- Register for an account with Dzengi.com.
- Deposit funds (with crypto or fiat) in the account.
- Determine the position size desired, accounting for leverage offered by Dzengi.com.
- Determine your trading position (long or short) based on expected share price movement and purchase tokenised Novavax shares derivatives. Dzengi.com matches the long orders from its clients with the sell orders and then hedges the unmatched orders through Capital.com, LMAX Digital or exchanges such as Binance, Bitstamp, Kraken, NASDAQ, NYSE and Gain Capital.
- Close your position when applicable. You can set a take-profit or stop-loss indicator to ensure you are not required to constantly monitor the price. Funds will deposit back to your account after closing and you can withdraw or take a new position.
Why trade tokenised Novavax shares with Dzengi.com
Novavax stock trading at Dzengi.com tokenised assets exchange has a number of advantages. Tokens are underpinned by robust and immutable blockchain technology. Opening a trade will give you a token that tracks and moves according to the underlying instrument's price.
- One-stop crypto trading platform
Trade tokenised Novavax shares with Bitcoin or Ethereum. Benefit from the stock's price movements without turning your crypto assets into fiat.
- Tight spreads
Trade tokenised shares with a tight market spread, benefit from maker rebates and competitive taker fees.
- Leverage
Experienced traders can trade the world's top stocks, like NVAX, with up to 1:500 leverage.
- Effective risk management
Manage your risks and secure your profits with stop-loss and take-profit orders. Save your assets with negative balance protection.
- Instant order execution
We have a scalable and low latency order management system, which can execute 50 million trades per second.
- Safe regulation
Dzengi.com operates under new Belarusian regulation with best-in-class AML and KYC laws. Regulatory details and fees are upfront.
